Trial Profile
A Phase II study of chemotherapy and pamidronate for the treatment of newly diagnosed osteosarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2016
Price :
$35
*
At a glance
- Drugs Pamidronic acid (Primary) ; Cisplatin; Doxorubicin; Methotrexate
- Indications Osteosarcoma
- Focus Therapeutic Use
- 12 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 May 2007 Status changed from recruiting to in progress.